# Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency

> **NCT00227409** · NA · COMPLETED · sponsor: **Chang Gung Memorial Hospital**

## Conditions studied

- Urologic Disease

## Interventions

- **DRUG:** calcium disodium EDTA (edetate calcium disodium)

## Key facts

- **NCT ID:** NCT00227409
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** — (—)
- **Last updated:** 2006-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00227409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00227409, "Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00227409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*